Mateus Luz Levandowski1, Saulo Gantes Tractenberg1, Lucas Araújo de Azeredo1, Tatiana De Nardi1, Diego L Rovaris2, Claiton H D Bau2, Lucas B Rizzo3, Pawan Kumar Maurya3, Elisa Brietzke3, Audrey R Tyrka4, Rodrigo Grassi-Oliveira1. 1. Developmental Cognitive Neuroscience Lab (DCNL), Biomedical Research Institute (IPB), Pontifical Catholic University of Rio Grande do Sul (PUCRS), Brazil. 2. Department of Genetics, Instituto de Biociências, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil. 3. Research Group in Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil. 4. Mood Disorders Research Program and Laboratory for Clinical and Translational Neuroscience, Department of Psychiatry and Human Behavior, Brown University, USA.
Abstract
BACKGROUND: Early life stress (ELS) and addiction are related to age-related diseases and telomere shortening. However, the role of telomere length (TL) in crack cocaine addiction remains unknown. The purpose of this study was to investigate the TL in a sample of crack cocaine dependent-women who reported an ELS history and in a community-based sample of elderly women as a reference group for senescence. METHODS: This study included treatment seeking crack cocaine dependents women (n=127) and elderly women without a psychiatric diagnosis (ELD, n=49). The crack cocaine sample was divided in two groups according to their Childhood Trauma Questionnaire (CTQ) scores: presence of history of childhood abuse and neglect (CRACK-ELS) and absence of ELS history (CRACK). TL was assessed by T/S ratio obtained from peripheral blood DNA using quantitative PCR assay. RESULTS: CRACK and CRACK-ELS subjects exhibited shortened TL in comparison to the ELD group, despite their younger age. Among crack cocaine sample, CRACK-ELS group had significantly shorter telomeres than the CRACK group. Correlation analysis within crack cocaine group indicated that TL was negatively correlated with emotional abuse scores. CONCLUSIONS: These results support previous findings associating telomere shortening with both ELS and drug addiction. This study suggests new evidence of a distinct biological phenotype for drug-dependent women with ELS. The results support the biological senescence hypothesis underpinning ELS experience.
BACKGROUND: Early life stress (ELS) and addiction are related to age-related diseases and telomere shortening. However, the role of telomere length (TL) in crack cocaine addiction remains unknown. The purpose of this study was to investigate the TL in a sample of crack cocaine dependent-women who reported an ELS history and in a community-based sample of elderly women as a reference group for senescence. METHODS: This study included treatment seeking crack cocaine dependents women (n=127) and elderly women without a psychiatric diagnosis (ELD, n=49). The crack cocaine sample was divided in two groups according to their Childhood Trauma Questionnaire (CTQ) scores: presence of history of childhood abuse and neglect (CRACK-ELS) and absence of ELS history (CRACK). TL was assessed by T/S ratio obtained from peripheral blood DNA using quantitative PCR assay. RESULTS:CRACK and CRACK-ELS subjects exhibited shortened TL in comparison to the ELD group, despite their younger age. Among crack cocaine sample, CRACK-ELS group had significantly shorter telomeres than the CRACK group. Correlation analysis within crack cocaine group indicated that TL was negatively correlated with emotional abuse scores. CONCLUSIONS: These results support previous findings associating telomere shortening with both ELS and drug addiction. This study suggests new evidence of a distinct biological phenotype for drug-dependent women with ELS. The results support the biological senescence hypothesis underpinning ELS experience.
Authors: Shenghan Lai; Christopher M Heaphy; Anthony J Rizzo; David D Celentano; Gary Gerstenblith; Ji Li; Richard D Moore; Glenn Treisman; Shaoguang Chen; Parker Foster; Thomas Kickler; Hong Lai Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2018-02-02 Impact factor: 5.067
Authors: Jonika Tannous; Benson Mwangi; Khader M Hasan; Ponnada A Narayana; Joel L Steinberg; Consuelo Walss-Bass; F Gerard Moeller; Joy M Schmitz; Scott D Lane Journal: PLoS One Date: 2019-01-09 Impact factor: 3.240
Authors: David Bürgin; Aoife O'Donovan; Delfine d'Huart; Alain di Gallo; Anne Eckert; Jörg Fegert; Klaus Schmeck; Marc Schmid; Cyril Boonmann Journal: Front Neurosci Date: 2019-05-22 Impact factor: 4.677
Authors: Fernando Navarro-Mateu; María Rubio-Aparicio; Pedro Cayuela; Francisco-Javier Álvarez; Agustín Roca-Vega; María Dolores Chirlaque; María Luisa Cayuela; Mathilde Husky; Salvador Martínez; Julio Sánchez-Meca Journal: Syst Rev Date: 2019-12-01